More on MAKO Surgical (MAKO): Q3 beats consensus on both EPS and revenue, but the company lowers...

|About: MAKO Surgical Corp. (MAKO)|By:, SA News Editor

More on MAKO Surgical (MAKO): Q3 beats consensus on both EPS and revenue, but the company lowers its guidance for MAKOplasty procedures in Q4, based on the total procedures performed in the first three quarters of FY12 and the unknown net effect of Hurricane Sandy. It now expects to perform between 10,200 to 10,600 procedures, down from prior guidance of 11K to 12K. FY12 annual guidance of 42 - 48 expected RIO system sales remains unchanged. Shares -1.4% AH.